© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
August 2nd 2021, 1:00pm
A survivor of osteosarcoma who underwent treatment in the 1960s in a segregated hospital ward, shares how he was able to find strength during that time.
July 30th 2021, 11:00pm
CURE spoke with Dr. Rajiit Rampal, on behalf of the MPN Research Foundation, about MPN symptoms and their management.
CURE spoke with Brandon Goetzman, board member from the MPN Research Foundation, on elevating the patient’s voice when it comes to their care for myeloproliferative neoplasms.
CURE spoke with Dr. Gabriela Hobbs, on behalf of the MPN Research Foundation, about the need for clinical trial education for patients with myeloproliferative neoplasms.
CURE spoke with Dr. Rajiit Rampal, on behalf of the MPN Research Foundation, about disease progression in myeloproliferative neoplasms.
CURE spoke with Dr. Gabriela Hobbs, on behalf of the MPN Research Foundation, about currently available treatment options, as well as those under clinical investigation, for patients with myeloproliferative neoplasms.
July 30th 2021, 1:00pm
Rob Paulsen is the voice behind many beloved cartoon characters, but after receiving a cancer diagnosis, he discovered a whole new way to relate to others.
July 28th 2021, 2:04pm
Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.
July 28th 2021, 1:58pm
The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.
July 27th 2021, 2:13pm
Dr Thomas E. Hutson comments on the rationale for using combination immune therapy, as well as a combination of immune therapy and an oral VEGF inhibitor for initial treatment of RCC.
3 Ways to Get Cancer Off Your Back
Pregnant Women With Previous or Current Cancer Diagnoses May Experience More Complications During Delivery
Navigating the Unknown of Rare Cancers
Playing With House Money: Defying Cancer Odds